Vor Biopharma Inc.
VOR
$23.66
-$1.44-5.74%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -62.81M | -219.59M | 1.72B | -812.68M | -1.57B |
| Total Depreciation and Amortization | 36.00K | 28.00K | 23.00K | 2.00K | 2.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.38M | 196.85M | -1.75B | 753.96M | 1.53B |
| Change in Net Operating Assets | 9.01M | -15.54M | 3.16M | 5.06M | 4.63M |
| Cash from Operations | -25.38M | -38.25M | -22.80M | -53.66M | -35.18M |
| Capital Expenditure | -120.00K | -48.00K | -314.00K | -244.00K | -152.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 799.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.41M | -263.19M | -48.66M | -- | -1.00K |
| Cash from Investing | -36.53M | -263.24M | -48.97M | -244.00K | 646.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.00K | 75.00M | 483.08M | 22.21M | 97.00K |
| Repurchase of Common Stock | -2.00K | -2.00K | -148.00K | -19.00K | -32.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -107.00K | -127.00K | -175.13M | -643.00K | 175.00M |
| Cash from Financing | -106.00K | 74.87M | 307.80M | 21.55M | 175.07M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.02M | -226.61M | 236.02M | -32.36M | 140.53M |